Abstract

Nihilism has been pervasive in the acute kidney injury field for decades, given that no studies, had been able to reduce AKI rates in hospitalized patients. Furthermore, children with AKI comprise an orphan population, where there is little incentive to develop diagnostics, therapeutics or devices specifically for them. The 3rd International Symposium on Acute Kidney Injury in Children, held in Cincinnati in October 2018, provided a platform to demonstrate the advancements in the diagnosis and treatment of children with, or at-risk for AKI, and also highlighted barriers to advancing care for this population. The progress made in the pediatric AKI since the 2nd International Symposium in 2016, highlighted the positive outcomes emanating from federal agency, private foundation and corporate sponsor investment in pediatric AKI. As a result, the time should be over for nihilism in the pediatric field.

Highlights

  • Nihilism comes from the Latin nihil, or nothing

  • A commonly held belief among intensivists and nephrologists is that patients die with, and not of, acute renal failure (ARF);

  • The 3rd International Symposium on Acute Kidney Injury in Children, held in Cincinnati in October 2018, provided a platform to demonstrate the advancements in the diagnosis and Ending Nihilism in Pediatric AKI

Read more

Summary

INTRODUCTION

Nihilism comes from the Latin nihil, or nothing. It is the belief that values are falsely invented. A commonly held belief among intensivists and nephrologists is that patients die with, and not of, acute renal failure (ARF);. Implicit in these statements a heralding of a turning point from in the perspective from ignorance to nihilism, which in many cases, persists today. These statements reflect the authors’ hope that since patients are dying from and not just with their acute renal failure, it is incumbent upon clinician researchers in the field to not give into nihilism, but do something about it

PROGRESS IN PEDIATRIC AKI
AKI Biomarker Directed Care Algorithms
Findings
CONCLUSIONS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.